HMG-CoA reductase inhibitors, commonly referred to as statins, are the cornerstone of pharmacologic reduction of elevated low-density lipoprotein cholesterol ... level of 190 mg/dL or higher ...

The Collaborative Atorvastatin Diabetes Study 2 investigated the effectiveness of atorvastatin (10 mg daily) versus placebo for prevention of major cardiovascular events in 2,838 diabetic patients.